MedPath

MacLeods Pharmaceuticals Ltd.

MacLeods Pharmaceuticals Ltd. logo
🇮🇳India
Ownership
Private
Established
1989-01-01
Employees
10K
Market Cap
-
Website
http://www.macleodspharma.com

Clinical Trials

24

Active:0
Completed:1

Trial Phases

4 Phases

Phase 1:1
Phase 3:9
Phase 4:6
+1 more phases

Drug Approvals

12

SFDA:7
NMPA:5

Drug Approvals

Pramipexole Dihydrochloride Sustained Release Tablets

Product Name
盐酸普拉克索缓释片
Approval Number
国药准字HJ20230136
Approval Date
Dec 5, 2023
NMPA

Pramipexole Dihydrochloride Sustained Release Tablets

Product Name
盐酸普拉克索缓释片
Approval Number
国药准字HJ20230138
Approval Date
Dec 5, 2023
NMPA

Pramipexole Dihydrochloride Sustained Release Tablets

Product Name
盐酸普拉克索缓释片
Approval Number
国药准字HJ20230135
Approval Date
Dec 5, 2023
NMPA

Pramipexole Dihydrochloride Sustained Release Tablets

Product Name
盐酸普拉克索缓释片
Approval Number
国药准字HJ20230137
Approval Date
Dec 5, 2023
NMPA

Pramipexole Dihydrochloride Sustained Release Tablets

Product Name
盐酸普拉克索缓释片
Approval Number
国药准字HJ20230139
Approval Date
Dec 5, 2023
NMPA

Clinical Trials

Distribution across different clinical trial phases (20 trials with phase data)• Click on a phase to view related trials

Phase 3
9 (45.0%)
Phase 4
6 (30.0%)
Not Applicable
4 (20.0%)
Phase 1
1 (5.0%)

Bronchoprovocation Study to Demonstrate the Pharmacodynamic Bioequivalence of Albuterol Sulfate HFA Inhalation Aerosol (E.Q. 90 mcg of Albuterol Base/Inh) of Macleods Pharmaceuticals Ltd

Phase 3
Not yet recruiting
Conditions
Mild Asthma
Interventions
First Posted Date
2024-10-01
Last Posted Date
2024-10-03
Lead Sponsor
Macleods Pharmaceuticals Ltd
Target Recruit Count
144
Registration Number
NCT06618105
Locations
🇮🇳

Multiple Locations, Multiple Locations, India

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.